FDC Limited has informed the Exchange regarding Outcome of Board Meeting held on May 27, 2026.
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
FDC Limited reported audited standalone net profit of ₹28,592.34 lakhs for FY2026, up 4.5% from ₹27,362.60 lakhs in FY2025. Consolidated net profit stood at ₹28,142.16 lakhs, up 5.5% year-on-year. Standalone revenue from operations grew 2.7% to ₹2,12,633 lakhs, while consolidated revenue increased 3% to ₹2,17,003 lakhs. The auditors (BSR & Co. LLP) issued an unmodified (clean) opinion on both standalone and consolidated results. An exceptional item of ₹2,078.91 lakhs was recognized due to new labour code obligations - this is a one-time, non-recurring expense. The board also re-appointed GMVP & Associates as Cost Auditor and Ford, Rhodes, Parks & Co. as Tax Auditor for FY2027.
The company delivered steady but modest profit growth of around 5% with clean audit results. The exceptional labour code charge of ₹2,078.91 lakhs reduced reported profits but is non-recurring, so underlying earnings quality remains stable. The stock appears supported by consistent performance in the pharmaceuticals segment.